The global biosurgery market was valued at USD 25.69 billion in 2023 and is expected to reach USD 35.85 billion by 2030, expanding at a compound annual growth rate (CAGR) of 4.7% from 2024 to 2030. Market growth is primarily driven by the rising preference for minimally invasive surgical procedures, along with continuous advancements in healthcare-related scientific technologies.

Biosurgery involves the use of biomaterials rather than synthetic alternatives during surgical procedures to support tissue reconstruction, improve surgical outcomes, accelerate patient recovery, and promote tissue regeneration. The growing demand for such procedures is reinforcing the adoption of biosurgical products across multiple medical disciplines.

Key Market Trends & Insights

  • North America accounted for the largest revenue share of 50.1% in 2023, maintaining its dominant market position.
  • Asia Pacific is projected to register the fastest CAGR of 6.0% during the forecast period.
  • By product, surgical sealants led the market with a 26.9% revenue share in 2023.
  • By application, general surgery emerged as the leading segment in 2023.
  • Increasing adoption of minimally invasive procedures is supporting long-term market expansion.

Market Size and CAGR

  • 2023 Market Size: USD 25.69 Billion
  • 2030 Projected Market Size: USD 35.85 Billion
  • CAGR (2024–2030): 4.7%
  • Largest Regional Market (2023): North America
  • Fastest Growing Region: Asia Pacific

The increasing prevalence of chronic diseases, including cancer, cardiovascular disorders, arthritis, non-communicable diseases, and other health conditions, is expected to significantly elevate demand for biosurgical products over the coming years. Additionally, the growing geriatric population across several countries, which requires ongoing medical care and is more susceptible to multiple health complications, is further accelerating market growth.

A rise in accidents and sports-related injuries is also contributing to increased biosurgery adoption. According to the World Health Organization (WHO), approximately 4.4 million deaths occur annually worldwide due to injuries, accounting for 8% of total global deaths, with nearly one-third of injury-related fatalities resulting from road traffic accidents. These factors are expected to create sustained demand for biosurgical interventions.

Ongoing advancements in biosurgical product development and increased adoption of innovative solutions by key industry players are positively influencing market growth. Products such as surgical sealants, adhesion barriers, and hemostatic agents are increasingly utilized to improve the effectiveness and outcomes of minimally invasive surgeries. The integration of advanced surgical tools and biosurgical techniques is further expanding growth opportunities across healthcare facilities worldwide.

Order a free sample PDF of the Biosurgery Market Intelligence Study, published by Grand View Research.

Key Biosurgery Company Insights

Leading companies operating in the biosurgery market include Medtronic, Sanofi, Baxter, Pfizer Inc., and others. To remain competitive, these organizations are actively focusing on strategies such as product differentiation, strategic collaborations, and innovation-driven product development.

  • Baxter is a prominent player offering a comprehensive portfolio of biosurgical products, including surgical hemostats and sealants. Its key offerings include Floseal Hemostatic Matrix, PERCLOT Absorbable Hemostatic Powder, TISSEEL fibrin sealant, ARTISS fibrin sealant, COSEAL surgical sealant, and PREVELEAK surgical sealant, among others.
  • Artivion, Inc. (formerly CryoLife|Jotec) is another major participant, providing heart valve solutions, aortic and peripheral vascular grafts, and surgical sealants. Its notable biosurgery product includes BioGlue surgical adhesive.

Key Biosurgery Companies

  • Sanofi
  • Baxter
  • INTEGRA LIFESCIENCES
  • Medtronic
  • Braun SE
  • Pfizer Inc
  • Stryker
  • Johnson & Johnson Services, Inc
  • BD
  • Artivion, Inc. (CryoLife, Inc.)

Conclusion

In conclusion, the global biosurgery market is poised for steady growth through 2030, supported by rising demand for minimally invasive procedures, increasing chronic disease prevalence, and rapid technological advancements in biosurgical products. The dominance of North America, coupled with strong growth prospects in Asia Pacific, highlights the market’s global expansion potential. Continued innovation, product development, and strategic initiatives by leading market participants are expected to further strengthen the adoption of biosurgery solutions and drive sustained market growth during the forecast period.

Explore Horizon Databook – The world’s most expansive market intelligence platform developed by Grand View Research.